Back to results
US 11,007,168 B2Granted
Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
AssigneesCurrax Pharmaceuticals LLC, ProCom One, Inc.
InventorsSusan E. Dubé, Neil B. Kavey
Life of this patent
Estimating the term…
Abstract
The invention relates to use of the trans-(E) isomer or isomeric mixtures containing specified ratios of the trans-(E) and cis-(Z) isomers of doxepin, metabolites of doxepin, pharmaceutically-acceptable salts of doxepin and prodrugs of the same; compositions containing the same, for the treatment of sleep disorders.
Claims20
A method for treating insomnia, the method comprising:
- administering an oral formulation comprising doxepin or a pharmaceutically acceptable salt thereof to a patient having a sleep disorder in which, for a given 8 hour period of desired sleep, the patient has difficulty staying asleep during the final 60 minutes of said period, wherein the oral formulation comprises a dosage of doxepin between about 1 and about 7 mg, wherein the doxepin or salt thereof is a geometric isomer mixture containing about 88.3% to about 100.0% of the trans-(E) isomer or is 100% trans-(E) isomer, and wherein the dosage is administered prior to the start of the sleep period.
Dependencies are inferred from the claim text.